C4A and urinary bladder cancer: According to the TISIDB website, we evaluated the expression distribution ofPRR13 in the immune subtypes of bladder cancer, and found that its expression varied among different immune subtypes, and that the highest expression of C4 was observed (lymphocyte depleted) (Fig. 4E).